Ebolavirus and haemorrhagic syndrome
SQUMJ-Sultan Qaboos University Medical Journal. 2015; 15 (2): 155-160
Dans Anglais
| IMEMR
| ID: emr-171455
ABSTRACT
The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world's most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Zaire, Reston and Tai Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Filoviridae
/
Fièvre hémorragique à virus Ebola
/
Prise en charge de la maladie
Limites du sujet:
Animaux
/
Humains
langue:
Anglais
Texte intégral:
Sultan Qaboos Univ. Med. J.
Année:
2015
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS